Trial Profile
An open-label study of argatroban injection to evaluate the safety and effectiveness in pediatric patients requiring anticoagulant alternatives to heparin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Aug 2023
Price :
$35
*
At a glance
- Drugs Argatroban (Primary)
- Indications Thrombosis
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 10 Jul 2007 New trial record.